NexGel, Inc.

NXGL Healthcare Medical Instruments & Supplies

NexGel, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.4 million, up 31.5% from fiscal 2024. In the quarter to June 2026, revenue grew 27.8%, EPS fell 344.4%, free cash flow fell 432.3% and total debt rose 353.8%, each against the same quarter a year earlier. Dividend growth for three consecutive years, revenue growth for five.

5.59 0.41 +7.92%
Market cap
$15.9M
P/E
0.0×
Fwd P/E
−4.7×
Dividend yield
—
F-score
5/9
Altman Z
24.63
Beneish M
−3.41
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

6 5 4 1
ROE
(54.54%) (54.69%) (63.98%) (117.57%)
ROA
(25.96%) (27.98%) (29.18%) (34.21%)
ROIC
(41.45%) (45.90%) (50.63%) (45.29%)
Return on Tangible Assets
(67.13%) (89.90%) (76.28%) 97.23%
Average Days of Receivables
26.25 21.51 21.45 32.64
Free Cash Flow per Share
(0.32) (0.18) (0.18) (0.37)
Free Cash Flow
(2.56) (1.45) (1.49) (3.34)
Other line items

Show all line items

Columns are period end dates